Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease
Yi Sun, Jiaxuan Huang, Yufei Chen, et al.
Bioorganic Chemistry (2020) Vol. 103, pp. 104172-104172
Open Access | Times Cited: 51

Showing 26-50 of 51 citing articles:

Fragment-Based Discovery of Azocyclic Alkyl Naphthalenesulfonamides as Keap1-Nrf2 Inhibitors for Acute Lung Injury Treatment
Jianyu Yan, Yue Li, Ding Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 12, pp. 8267-8280
Closed Access | Times Cited: 12
Medicinal Chemistry Insights into the Development of Small-Molecule Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Protein–Protein Interaction Inhibitors
Ziquan Zhao, Ruitian Dong, Qidong You, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9325-9344
Closed Access | Times Cited: 11
Patenting perspective on Keap1 inhibitors (2019-2024)
Yue Luo, Wenlong Yang, Yuan Zhang, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Health position paper and redox perspectives – Bench to Bedside Transition for Pharmacological Regulation of NRF2 in Noncommunicable Diseases
Antonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
Redox Biology (2025), pp. 103569-103569
Open Access
Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease
Yi Sun, Lijuan Xu, Hongming Shao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14957-14969
Closed Access | Times Cited: 17
Targeting kelch-like (KLHL) proteins: achievements, challenges and perspectives
Yangguo Zhou, Qiong Zhang, Ziquan Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116270-116270
Closed Access | Times Cited: 3
Epigallocatechin-3-Gallate Inhibits Oxidative Stress Through the Keap1/Nrf2 Signaling Pathway to Improve Alzheimer Disease
Shi Tang, Yong Zhang, Benson O. A. Botchway, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 Inhibitors
Yuting Qin, Cecilie Poulsen, Dilip Narayanan, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Posttranscriptional regulation of Nrf2 through miRNAs and their role in Alzheimer's disease
Ravinder K. Kaundal, Ashok Kumar Datusalia, Shyam Sundar Sharma
Pharmacological Research (2021) Vol. 175, pp. 106018-106018
Closed Access | Times Cited: 22
Novel Hydrogen Sulfide Hybrid Derivatives of Keap1-Nrf2 Protein–Protein Interaction Inhibitor Alleviate Inflammation and Oxidative Stress in Acute Experimental Colitis
Xian Zhang, Keni Cui, Xiaolu Wang, et al.
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1062-1062
Open Access | Times Cited: 8
All roads lead to Rome — a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimer’s disease
Kwok–Fai So, Ang Li, Yiyao Liang, et al.
Neural Regeneration Research (2021) Vol. 17, Iss. 6, pp. 1210-1210
Open Access | Times Cited: 18
Research Progress on the Preparation and Function of Antioxidant Peptides from Walnuts
Yuxi Hu, Ce Ni, Yingying Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14853-14853
Open Access | Times Cited: 7
Developing theragnostics for Alzheimer's disease: Insights from cancer treatment
Hyunju Lee, Hee-Jeong Choi, Yoo Joo Jeong, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131925-131925
Open Access | Times Cited: 2
The potential role of Keap1-Nrf2 pathway in the pathogenesis of Alzheimer’s disease, type 2 diabetes, and type 2 diabetes-related Alzheimer’s disease
Ling He, Yi Sun
Metabolic Brain Disease (2021) Vol. 36, Iss. 7, pp. 1469-1479
Closed Access | Times Cited: 16
Neuroprotective effect of a Keap1-Nrf2 Protein-Protein Inter-action inhibitor on cerebral Ischemia/Reperfusion injury
Zengxin Qi, Yusheng Tong, Hao Luo, et al.
Bioorganic Chemistry (2023) Vol. 132, pp. 106350-106350
Closed Access | Times Cited: 5
Development of 5-hydroxyl-1-azabenzanthrone derivatives as dual binding site and selective acetylcholinesterase inhibitors
Xiaona Sun, Yujin Wang, Zhichao Lei, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114210-114210
Closed Access | Times Cited: 8
TGF-β3 Protects Neurons Against Intermittent Hypoxia-Induced Oxidative Stress and Apoptosis Through Activation of the Nrf-2/KEAP1/HO-1 Pathway via Binding to TGF-βRI
Yinpei Huang, Zhili Liu, Xin Wang, et al.
Neurochemical Research (2023) Vol. 48, Iss. 9, pp. 2808-2825
Closed Access | Times Cited: 4
The untapped potential of targeting NRF2 in neurodegenerative disease
Wei-Tai Chen, Matthew Dodson
Frontiers in Aging (2023) Vol. 4
Open Access | Times Cited: 4
Innovative medicinal chemistry strategies for enhancing drug solubility
Zhangxu He, Weiguang Yang, Feifei Yang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116842-116842
Closed Access | Times Cited: 1
Targeting Proteins in Nucleus through Dual-Regulatory Pathways Acting in Cytoplasm
Xia Wu, Jingjing Hu, Lulu Chen, et al.
Nano Letters (2023) Vol. 23, Iss. 12, pp. 5811-5821
Closed Access | Times Cited: 3
Dehydroeburicoic Acid, a Dual Inhibitor against Oxidative Stress in Alcoholic Liver Disease
Shasha Cheng, Yi Kuang, Guodong Li, et al.
Pharmaceuticals (2022) Vol. 16, Iss. 1, pp. 14-14
Open Access | Times Cited: 3
New Insights into Strategies for Solubility Improvement
Zhangxu He, Weiguang Yang, Fei Yang, et al.
(2024)
Closed Access
DDO1002, an NRF2–KEAP1 inhibitor, improves haematopoietic stem cell aging and stress response
Yuwen Li, A H Wu, Xinrong Jin, et al.
Life Medicine (2024) Vol. 3, Iss. 6
Open Access
New phenolic glycosides from Anemone chinensis Bunge and their antioxidant activity
Zeng-Guang Zhang, Yuanyuan Li, Bin Lin, et al.
Natural Product Research (2021) Vol. 36, Iss. 19, pp. 5009-5015
Open Access | Times Cited: 3
Exposure to footshock stress downregulates antioxidant genes and increases neuronal apoptosis in an Aβ(1–42) rat model of Alzheimer's disease
Oluwaseun Samuel Faborode, Ernest Dallé, Musa V. Mabandla
Neurochemistry International (2021) Vol. 150, pp. 105170-105170
Closed Access | Times Cited: 1

Scroll to top